cj red bio anticancer drug
Scope
Date
~
-
Korean food
Bibigo, K-food a success case in Harvard Business School study
Harvard Business School students are set to study the success of South Korean foods in the global market through the case of Bibigo, the leading bra...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Jan 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand Yuflyma supply network in Europe
South Korea’s Celltrion Inc. announced on Friday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatment ...
Jan 12, 2024 (Gmt+09:00)
-
K-pop
CJ ENM to hold KCON Hong Kong in March
South Korea’s entertainment powerhouse CJ ENM Co. announced on Thursday that it will hold its annual K-pop festival KCON in Hong Kong for the ...
Jan 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for interchangeability of Yuflyma in US
South Korea's Celltrion Inc. announced on Wednesday that it has applied to the US Food and Drug Administration (FDA) for a modified approval to repl...
Jan 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Kobiolabs gets US patent for oral obesity drug candidate
Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...
Jan 10, 2024 (Gmt+09:00)
-
Shipping & Shipbuilding
Korea’s HMM among shippers benefiting from growing Red Sea crisis
The Red Sea crisis, disrupting the passage of ships through the Suez Canal, a central artery for global trade, is a bane for exporters looking for s...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm, Dong-A ST sign licensing deal of Cenobamate
South Korea's SK Biopharmaceuticals Co. announced on Thursday that it has signed a contract with Dong-A ST to transfer the rights to commercialize t...
Jan 04, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Korean food
CJ CheilJedang to boost K-Street Food exports
Korean food giant CJ CheilJedang Corp. is seeing major success with its "K-Street Food" line, a selection of iconic Korean street snacks with global...
Jan 02, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion to sell portfolio of Takeda drugs to CBC Group
South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...
Jan 01, 2024 (Gmt+09:00)
-
Food & Beverage
CJ CheilJedang opens online B2B section
South Korean food giant CJ CheilJedang Corp. introduced a business-to-business (B2B) section CJ The Market for Biz on its e-commerce website CJ The ...
Dec 29, 2023 (Gmt+09:00)
-
Food & Beverage
Shinsegae to close whisky business to focus on profits
Shinsegae Inc., South Korea’s largest department store and supermarket company, will pull out of the whisky market, bucking the trend of the r...
Dec 28, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung Elec moves a step closer to CXL commercialization
Samsung Electronics Co. seeking to lead the next-generation memory market has moved a step closer to commercializing computer express link (CXL)-bas...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
ViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
J&J seeks US, European approval for drug developed with Yuhan
Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...
Dec 22, 2023 (Gmt+09:00)
-
Food & Beverage
CJ CheilJedang to launch Excycle Basak Chip in global market
South Korean food company CJ CheilJedang Corp. announced on Thursday that it introduced its Excycle Basak Chip, a snack born from their in-house ven...
Dec 21, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
CJ Olive Young opens pop-up at @cosme Tokyo
South Korea's health and beauty store chain CJ Olive Young announced on Thursday that it opened a pop-up store at @cosme Tokyo, Japan’s larges...
Dec 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung, HK inno.N to co-market Kanarb, K-CAB
South Korea’s pharmaceutical companies Boryung Corp. and HK inno.N announced on Wednesday that they will start co-marketing for their respec...
Dec 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Icure wins $2.85 mn lidocaine cataplasm order from Guatemala
South Korea's Icure Pharmaceutical Incorporation announced on Tuesday that it signed a supply contract for the specialized local anesthetic lidoca...
Dec 19, 2023 (Gmt+09:00)
-
Food & Beverage
CJ Foodville attracts $54 mn investment from Arges PE
CJ Foodville, the food service subsidiary of South Korea's CJ Group and the operator of bakery brand Tous les Jours announced on Thursday that it at...
Dec 14, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N reveals differentiated clinical results for K-CAB
South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Entertainment
Toho buys 25% stake in CJ ENM’s Fifth Season for $225 mn
Toho Co. has acquired a 25% stake in Fifth Season for $225 million, a move expected to be a win for not only the money-losing US-based producer-dist...
Dec 12, 2023 (Gmt+09:00)
-
Corporate strategy
Samsung launches new growth engine control tower at mobile division
Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, has created a business control tower within its Digital eX...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio mulls name change after defeat to Lego
South Korean biopharmaceutical company LegoChem Biosciences Inc. is seeking to change its name after it lost in a trademark infringement lawsuit fil...
Dec 08, 2023 (Gmt+09:00)
-
Bio & Pharma
ISU Abxis gets patent for Alzheimer drug candidate in Taiwan
South Korea's ISU Abxis Co. announced on Friday that its Alzheimer's treatment candidate ISU203 has received a substance patent registration decisio...
Dec 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy bad consumer loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet